PERMAX Drug Patent Profile
✉ Email this page to a colleague
When do Permax patents expire, and what generic alternatives are available?
Permax is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in PERMAX is pergolide mesylate. There are four drug master file entries for this compound. Additional details are available on the pergolide mesylate profile page.
Summary for PERMAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 1 |
Patent Applications: | 3,405 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PERMAX at DailyMed |
Recent Clinical Trials for PERMAX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Colorado Neurology | Phase 3 |
Agarwal, Pinky, M.D. | Phase 3 |
GlaxoSmithKline | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for PERMAX
US Patents and Regulatory Information for PERMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-001 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-002 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | PERMAX | pergolide mesylate | TABLET;ORAL | 019385-003 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PERMAX
International Patents for PERMAX
See the table below for patents covering PERMAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 88087 | ⤷ Try a Trial | |
Australia | 4391779 | ⤷ Try a Trial | |
Japan | H0240044 | ⤷ Try a Trial | |
Australia | 2408088 | ⤷ Try a Trial | |
Australia | 6485390 | ⤷ Try a Trial | |
European Patent Office | 0314387 | STABILIZED PERGOLIDE COMPOSITIONS | ⤷ Try a Trial |
Japan | S54115400 | 66NNPROPYLL88METHOXYMETHYL OR METHYLMERCAPTO METHYLERGOLENES AND THEIR RELATIVE COMPOUNDS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PERMAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0003667 | SPC/GB93/063 | United Kingdom | ⤷ Try a Trial | SPC/GB93/063, EXPIRES: 20040204 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |